BIRC5 and hepatocellular carcinoma: Based on the pathogenesis of HCC, we conducted this prospective, cross-sectional, controlled study by using FGF-2, survivin, Ki67, endostatin, and VEGF activities to determine HCC recurrence before, early after, and late after LDLT.